$5.28
-0.09-1.68%
Últ. Act.: Oct 29, 4:34 PM
Tonix Pharmaceuticals (TNXP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.64 | $-2.51 | $-3.03 | $-3.09 |
| Actual | $-2.44 | $-2.93 | $-3.98 | $-3.59 |
| Surprise | +7.58% | -16.7% | -31.4% | -16.2% |
| Revenue | ||||
| Estimate | $7.8M | $7.4M | $2.9M | $2.3M |
| Actual | $13.5M | $6.9M | $5.4M | $3.3M |
| Surprise | +72.9% | -7.30% | +83.8% | +43.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-2.29 | $-2.27 | $-1.82 | $-1.67 |
| Revenue | ||||
| Consensus | $16.3M | $19.2M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-2.44 | $-2.64 | 7.58 % |
| Q1 | May 11, 2026 | $-2.93 | $-2.51 | -16.7 % |
| Q4 | Mar 12, 2026 | $-3.98 | $-3.03 | -31.4 % |
| Q3 | Nov 10, 2025 | $-3.59 | $-3.09 | -16.2 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $13.54M | $7.83M | 72.9 % |
| Q1 | May 11, 2026 | $6.88M | $7.42M | -7.30 % |
| Q4 | Mar 12, 2026 | $5.39M | $2.93M | 83.8 % |
| Q3 | Nov 10, 2025 | $3.29M | $2.30M | 43.0 % |